Abdulghani, J., Allen, J. E., Dicker, D. T., Liu, Y. Y., Goldenberg, D., Smith, C. D., . . . El-Deiry, W. S. (2013). Sorafenib Sensitizes Solid Tumors to Apo2L/TRAIL and Apo2L/TRAIL Receptor Agonist Antibodies by the Jak2-Stat3-Mcl1 Axis. Public Library of Science.

Abdulghani, Junaid, Joshua E. Allen, David T. Dicker, Yingqiu Yvette Liu, David Goldenberg, Charles D. Smith, Robin Humphreys, e Wafik S. El-Deiry. Sorafenib Sensitizes Solid Tumors to Apo2L/TRAIL and Apo2L/TRAIL Receptor Agonist Antibodies By the Jak2-Stat3-Mcl1 Axis. Public Library of Science, 2013.

Abdulghani, Junaid, et al. Sorafenib Sensitizes Solid Tumors to Apo2L/TRAIL and Apo2L/TRAIL Receptor Agonist Antibodies By the Jak2-Stat3-Mcl1 Axis. Public Library of Science, 2013.